247 related articles for article (PubMed ID: 31114322)
21. miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.
Du W; Zhang X; Wan Z
Onco Targets Ther; 2019; 12():4897-4906. PubMed ID: 31417285
[No Abstract] [Full Text] [Related]
22. MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.
Wang W; Zhang H; Tang M; Liu L; Zhou Z; Zhang S; Wang L
Oncol Lett; 2017 May; 13(5):3522-3528. PubMed ID: 28529580
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.
Cui H; Song R; Wu J; Wang W; Chen X; Yin J
Am J Cancer Res; 2018; 8(3):405-421. PubMed ID: 29636997
[TBL] [Abstract][Full Text] [Related]
25. miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.
Shi DM; Bian XY; Qin CD; Wu WZ
Onco Targets Ther; 2018; 11():571-585. PubMed ID: 29416358
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
27. miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R.
Hu Y; Yang Z; Bao D; Ni JS; Lou J
Pathol Res Pract; 2019 Dec; 215(12):152674. PubMed ID: 31732382
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.
Zhang C; Zhang J
Exp Ther Med; 2018 May; 15(5):4325-4331. PubMed ID: 29725374
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
32. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
33. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.
El Tayebi HM; Waly AA; Assal RA; Hosny KA; Esmat G; Abdelaziz AI
Oncol Lett; 2015 Nov; 10(5):3206-3212. PubMed ID: 26722313
[TBL] [Abstract][Full Text] [Related]
35. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.
Chang W; Zhang L; Xian Y; Yu Z
Exp Ther Med; 2017 May; 13(5):2507-2514. PubMed ID: 28565872
[TBL] [Abstract][Full Text] [Related]
37. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
38. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
39. MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R.
Ren L; Yao Y; Wang Y; Wang S
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31160483
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-223 promotes mast cell apoptosis by targeting the insulin-like growth factor 1 receptor.
Gao H; Deng H; Xu H; Yang Q; Zhou Y; Zhang J; Zhao D; Liu F
Exp Ther Med; 2016 Jun; 11(6):2171-2176. PubMed ID: 27284298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
